BILL ANALYSIS

S4085

BEARISH

Take Back Our Hospitals Act of 2026

S4085 (Take Back Our Hospitals Act of 2026) has been assessed with a bearish outlook for investors. The primary sectors impacted are Healthcare and Finance. View the full bill text on Congress.gov.

bearish

Market Sentiment

4/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

S4085 targets private equity ownership of hospitals/SNFs by prohibiting Medicare payments.

Early-stage bill with low probability of passage in the 119th Congress.

If enacted, Apollo ($APO) would be most negatively impacted; HCA ($HCA) would benefit from reduced competition.

How S4085 Affects the Market

The bill is too early-stage to drive immediate market moves. However, investors should watch for hearings or markup sessions that would increase passage probability. A sustained legislative push could pressure PE-owned hospital stocks and lift public hospital operators. No real market data is available for this bill, so positioning should be based on legislative momentum rather than current price action.

Bill Details

Metric	Value
Bill Number	S4085
Market Sentiment	bearish
Event Date	March 12, 2026
Affected Sectors	Healthcare, Finance
Source	View on Congress.gov →

Summary

The Take Back Our Hospitals Act of 2026 (S4085) would prohibit Medicare payments to hospitals and skilled nursing facilities owned by private equity firms. The bill is in early legislative stages with low near-term passage probability, but if enacted, it would negatively impact PE firms with hospital exposure like Apollo ($APO) and benefit public hospital operators like HCA ($HCA).

Full AI Market Analysis

The Take Back Our Hospitals Act of 2026 (S4085) was introduced by Sen. Murphy (D-CT) on March 12, 2026, and referred to the Senate Committee on Finance. It has a companion bill in the House (HR7920). The bill amends the Social Security Act to bar Medicare payments to hospitals or skilled nursing facilities owned or controlled by a 'covered firm' or its affiliates. The term 'covered firm' is not fully defined in the provided text but is widely understood to target private equity firms. The bill includes a three-year transition period for existing facilities. The money trail is indirect: the bill does not authorize or appropriate any funds. Instead, it creates a financial penalty—loss of Medicare revenue—for non-compliant facilities. Medicare is a major payer for hospitals and SNFs, so this prohibition would be a powerful disincentive for PE ownership. The mechanism is regulatory, not fiscal. Structural winners are publicly traded hospital operators not owned by PE, such as HCA Healthcare, Universal Health Services ($UHS), and Tenet Healthcare ($THC). These companies could gain market share and pricing power if PE-owned competitors exit or shrink. Structural losers are PE firms with significant hospital or SNF holdings, most notably Apollo Global Management ($APO) through its Lifepoint Health chain, and to a lesser extent Blackstone ($BX), KKR ($KKR), and others with healthcare investments. The bill is at an early stage—referred to committee with no hearings scheduled. Given the 119th Congress's divided control and the bill's partisan sponsorship (all Democrats), passage is unlikely in the current session. However, the bill signals growing regulatory scrutiny of PE in healthcare, which could influence future legislation or agency actions.